.svg)
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.png?width=91&height=92&name=img-container-(1).png)
The Australian Advantage
Cost
Eligible organisations receive a 43.5% cash rebate on trial costs with the Australian Research & Development tax incentive.
.svg)
Speed
Get you trial up and running in 8 weeks with streamlined ethics approvals and no need for an Investigational New Drug application.
Quality
World-class healthcare facilities and renowned experts ensure your data is accepted by international regulatory bodies like the FDA and EMA.
Come and meet us
Our team will be available throughout the BIO Europe Spring event to discuss how we can support your research initiatives. Whether you’re looking to start a new project, save an existing one or simply explore new partnership opportunities, we’re here to help.
Dr David Lloyd
Managing Director
- 30 years of research experience in academia, pharma & CROs
- Advisor to the Australian Government on Clinical Research reforms
- Appointed to NSW Dept Health Early Phase Expert Oversight Committee
- Previous member of several NHMRC committees overseeing clinical research
Lloyd Prescott
CEO
- 20 years of experience in medical devices, biotechnology, health services, and technology sectors.
- Degree in biomechanical engineering from the University of NSW
- Successfully launched two cell manipulation products.
- Deep insights into biotech regulatory compliance, supply chain management, and go-to-market strategies